XML 51 R25.htm IDEA: XBRL DOCUMENT v2.4.0.6
Geographic and Product Data
 12 Months Ended
Dec. 28, 2012
Segment Reporting [Abstract]  
Segment Reporting Disclosure [Text Block]

Note 18 — Geographic and Product Data

 

The Company markets and sells its products in approximately 60 countries and has manufacturing sites in the United States, Switzerland and Japan. Other than the United States, Japan, Korea, and China, the Company does not conduct business in any country in which its sales in that country exceed 5% of consolidated sales. Sales are attributed to countries based on location of customers. The composition of the Company’s sales to unaffiliated customers is set forth below (in thousands):

 

Net sales to unaffiliated customers   2012     2011     2010  
United States   $ 12,427     $ 13,852     $ 14,957  
Japan     16,692       15,690       13,607  
Korea     6,713       8,142       6,082  
China     8,406       6,354       3,910  
Others*     19,545       18,727       16,402  
Total   $ 63,783     $ 62,765     $ 54,958  

 

*No other location individually exceeds 5% of total sales.

 

100% of the Company’s sales are generated from the ophthalmic surgical product segment and, therefore, the Company operates as one operating segment for financial reporting purposes. The Company’s principal products are IOLs used in cataract surgery and ICLs used in refractive surgery.  The composition of the Company’s net sales by product line is as follows (in thousands):

 

Net sales by product line   2012     2011     2010  
ICLs   $ 35,080     $ 32,072     $ 24,300  
IOLs     25,971       27,547       27,550  
Other surgical products     2,732       3,146       3,108  
Total   $ 63,783     $ 62,765     $ 54,958  

 

The composition of the Company’s long-lived assets, consisting of property and equipment, between those in the United States, Switzerland, and Japan is set forth below (in thousands):

 

Long-lived assets   2012     2011  
U.S.   $ 3,052     $ 1,460  
Switzerland     984       1,010  
Japan     1,403       1,752  
Total   $ 5,439     $ 4,222  

 

The Company sells its products internationally, which subjects the Company to several potential risks, including fluctuating exchange rates (to the extent the Company’s transactions are not in U.S. dollars), regulation of fund transfers by foreign governments, United States and foreign export and import duties and tariffs, and political instability.